首页> 美国卫生研究院文献>other >Impact of hepatic function on serum procalcitonin for the diagnosis of bacterial infections in patients with chronic liver disease
【2h】

Impact of hepatic function on serum procalcitonin for the diagnosis of bacterial infections in patients with chronic liver disease

机译:肝功能对血清降钙素的影响对慢性肝病患者细菌感染的诊断

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Although procalcitonin (PCT) is a valid marker for early diagnosis of bacterial infections, it is unclear whether its accuracy in predicting bacterial infections is affected by impaired liver function. This study aimed to assess the impact of compromised liver function on the diagnostic value of PCT.This retrospective study was conducted between January 2013 and May 2015. A total of 324 patients with chronic liver disease were enrolled. Routine laboratory measurements and PCT were performed. Patients were divided into 3 groups according to clinical diagnosis: chronic hepatitis (group 1), decompensated cirrhosis (group 2), and acute-on-chronic liver failure/chronic liver failure (group 3). The correlation between PCT and liver function was analyzed. The area under the receiver operating characteristic (AUCROC) curve of PCT was analyzed according to infection status and liver function.PCT was more accurate than white blood cell count (P < 0.001) and percentage of neutrophils (P < 0.001) in detecting bacterial infections in patients with impaired liver function. In patients without infection, PCT had a moderate positive correlation with serum total bilirubin (TBIL) (r = 0.592), and a weak correlation with model for end-stage liver disease score (r = 0.483) and international normalized ratio (r = 0.389). The AUCROC and optimum thresholds of PCT and for predicting bacterial infections at different levels of TBIL were 0.907 (95% CI 0.828–0.958) and 0.38 ng/mL, respectively, for TBIL <5 mg/dL, 0.927 (95% CI 0.844–0.974) and 0.54 ng/mL (5 mg/dL ≤TBIL<10 mg/dL), 0.914 (95% CI 0.820–0.968) and 0.61 ng/mL (10 mg/dL ≤TBIL<20 mg/dL), 0.906 (95% CI 0.826–0.958) and 0.94 ng/mL (TBIL ≥20 mg/dL), respectively.This study demonstrated that PCT was a valuable marker of bacterial infection in patients with chronic liver diseases. TBIL affected PCT threshold, so different cut-offs should be used according to different TBIL values.
机译:尽管降钙素原(PCT)是早期诊断细菌感染的有效标志物,但尚不清楚其预测细菌感染的准确性是否受到肝功能受损的影响。这项研究旨在评估肝功能受损对PCT诊断价值的影响。这项回顾性研究于2013年1月至2015年5月进行。总共招募了324例慢性肝病患者。进行常规实验室测量和PCT。根据临床诊断将患者分为三组:慢性肝炎(第1组),失代偿性肝硬化(第2组)和急性慢性肝衰竭/慢性肝衰竭(第3组)。分析了PCT与肝功能之间的相关性。根据感染状况和肝功能分析了PCT接收者工作特征曲线下的面积(AUCROC),在检测细菌感染方面,PCT比白细胞计数(P <0.001)和中性粒细胞百分比(P <0.001)更准确肝功能受损的患者。在没有感染的患者中,PCT与血清总胆红素(TBIL)呈中等正相关(r = 0.592),与晚期肝病评分模型(r = 0.483)和国际标准化比率(r = 0.389)的相关性较弱。 )。对于TBIL <5 mg / dL,PCT的AUCROC和PCT最佳阈值以及用于预测细菌感染的最佳阈值分别为0.907(95%CI 0.828-0.958)和0.380.9ng / mL,0.927(95%CI 0.844-95) 0.974)和0.54 ng / mL(5 mg / dL≤TBIL<10 mg / dL),0.914(95%CI 0.820-0.968)和0.61 ng / mL(10 mg / dL≤TBIL<20 mg / dL),0.906 (95%CI 0.826-0.958)和0.94μng/ mL(TBIL≥20μmg/ dL)。这项研究表明PCT是慢性肝病患者细菌感染的重要标志。 TBIL影响PCT阈值,因此应根据不同的TBIL值使用不同的临界值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号